In CSSM programme drug of choice for Pneumonia:
**Core Concept**
The Community-based Services Scheme for Management (CSSM) of pneumonia aims to provide effective treatment for pneumonia in resource-limited settings. The choice of antibiotic is crucial in this context, considering factors like cost, efficacy, and potential resistance patterns.
**Why the Correct Answer is Right**
The correct answer, **Ceftriaxone**, is a third-generation cephalosporin antibiotic that is effective against a broad spectrum of bacteria, including those responsible for community-acquired pneumonia (CAP). Ceftriaxone has a strong affinity for the bacterial cell wall, inhibiting cell wall synthesis and ultimately leading to bacterial death. It is also relatively inexpensive and has a long half-life, making it an ideal choice for outpatient treatment.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because **Ampicillin** is a first-generation cephalosporin with limited activity against many gram-negative bacteria, making it less effective against CAP.
**Option B:** This option is incorrect because **Azithromycin** is a macrolide antibiotic that is effective against CAP but may not be the first-line choice due to concerns about resistance and potential interactions with other medications.
**Clinical Pearl / High-Yield Fact**
In the CSSM programme, ceftriaxone is often administered as a single intramuscular dose, which simplifies treatment and reduces the risk of non-adherence.
**Correct Answer: C. Ceftriaxone**